Arrhythmic Burden After Bruton's Tyrosine Kinase Inhibitor Initiation and Major Cardiovascular Events

被引：0
|
作者：
Gambril, John A.
Ghazi, Sanam
Sansoterra, Stephen
Ferdousi, Mussammat
Kola-Kehinde, Onaopepo
Ruz, Patrick
Kittai, Adam
Rogers, Kerry
Grever, Michael
Bhat, Seema
Wiczer, Tracy
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Cardio-oncology; Atrial fibrillation; Hematologic Disorders; Arrhythmias;
D O I：
10.1161/circ.148.suppl_1.13214Circulation
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13214
引用
收藏
页数：3
相关论文
共 50 条
  • [41] The many faces of Bruton's tyrosine kinase
    C Patrick McAtee
    Nature Biotechnology, 2012, 30 : 394 - 394
  • [42] The Promising Impact of Ibrutinib, a Bruton's Tyrosine Kinase Inhibitor, for the Management of Lymphoid Malignancies
    Bhatt, Valkal
    Alejandro, Linh
    Michael, Angela
    Ganetsky, Alex
    PHARMACOTHERAPY, 2014, 34 (03): : 303 - 314
  • [43] A fit for purpose synthesis of Bruton's tyrosine kinase inhibitor GDC-0852
    Lim, Ngiap-Kie
    Zhang, Haiming
    Sowell, C. Gregory
    Gosselin, Francis
    TETRAHEDRON LETTERS, 2020, 61 (44)
  • [44] The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Impairs the Vascular Development of Zebrafish Larvae
    Wang, Kun
    Xu, Qiushi
    Zhong, Hanbing
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [45] Modeling the Binding and Conformational Energetics of a Targeted Covalent Inhibitor to Bruton's Tyrosine Kinase
    Awoonor-Williams, Ernest
    Rowley, Christopher N.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2021, 61 (10) : 5234 - 5242
  • [46] Absence of Pharmacokinetic Interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate
    Jones, Nicholas Steven
    Winter, Helen
    Katsumoto, Tamiko R.
    Florero, Marilyn
    Murray, Elaine
    Walker, Helen
    Singh, Nand
    Chinn, Leslie W.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 371 (01): : 202 - +
  • [47] Novel Hemorrhagic Dermatologic Toxicity Associated with Bruton's Tyrosine Kinase Inhibitor Therapy
    Schmidt, Nicholas J., Jr.
    Isaac, Krista
    Williams, Michael E.
    Flowers, Richard
    Zufall, Alina
    Patel, Krishna
    BLOOD, 2021, 138
  • [48] Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)
    Burger, Jan A.
    Buggy, Joseph J.
    LEUKEMIA & LYMPHOMA, 2013, 54 (11) : 2385 - 2391
  • [49] The first oral Bruton Tyrosine Kinase Inhibitor for the Treatment of CLL
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (12) : 707 - 707
  • [50] Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton's Tyrosine Kinase
    Smith, Christopher R.
    Dougan, Douglas R.
    Komandla, Mallareddy
    Kanouni, Toufike
    Knight, Beverly
    Lawson, J. David
    Sabat, Mark
    Taylor, Ewan R.
    Phong Vu
    Wyrick, Corey
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (14) : 5437 - 5444
12345